Correction To: iHIVARNA Phase IIa, a Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety and Immunogenicity of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy
Trials - United Kingdom
doi 10.1186/s13063-019-3940-0
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC